| Document Date: 2008-03-11 07:45:47
Open Document File Size: 137,14 KBShare Result on Facebook
City GENEVA / London / / Company GlaxoSmithKline / Medicines / Malaria Venture / Glaxosmithkline plc / / Continent Africa / / Country Switzerland / Kenya / United Kingdom / / Event FDA Phase / Product Issues / Product Recall / / IndustryTerm anti-malarial product / fixed-dose combination antimalarial product / / MedicalCondition uncomplicated falciparum malaria / malaria / G6PD deficiency / deficiency / / MedicalTreatment blood transfusion / / Organization World Health Organization / Medicines and Healthcare products Regulatory Agency / / / Product post-treatment haemolytic anaemia / dapsone / Coartem / patients / Dacart / Coartem® / LapDap™ / LapDap / Dacart™ / / PublishedMedium The WHO / / Region sub-Saharan Africa / / URL WWW.WHO.INT / http /
SocialTag |
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +[removed] – FAX CENTRAL +[removed] – WWW.WHO.INT QSM/MC/IEA.117